Weight Loss Drugs Challenge Big Food As Diets Change

Weight Loss Drugs Challenge Big Food As Diets Change - Moby THE GIST Americans are making healthier choices, and Big Food is staring down a $12 billion bill over the next decade. GLP-1 weight-loss drugs like Ozempic, Mounjaro and Wegovy have reached 20% of U.S. households. Big Food’s counterattack involves removing additives, shrinking packages, sprinkling in protein and fiber, and hoping Sun Chips can outrun semaglutide. WHAT HAPPENED About one in five U.S. households now has someone taking a GLP-1 drug ...